These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice. Colston MJ, Hilson GR, Banerjee DK. Lepr Rev; 1978 Mar; 49(1):7-15. PubMed ID: 347206 [No Abstract] [Full Text] [Related]
11. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months. Innami S, Leguizamón OR, Alvarenga AE. Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957 [No Abstract] [Full Text] [Related]
12. Strategies in the development of new drugs and drug combinations against leprosy, demonstrated on the example of folate and gyrase inhibitors. Seydel JK, Rosenfeld M, Sathish M, Wiese M, Schaper KJ, Hachtel G, Haller R, Kansy M, Dhople AM. Lepr Rev; 1986 Jun; 57 Suppl 3():235-53. PubMed ID: 3033412 [No Abstract] [Full Text] [Related]
14. Application of ATP assay for in vitro drug screening testing against human derived M. leprae. Katoch VM, Katoch K, Shivannavar CT, Sharma VD, Patil MA, Bharadwaj VP. Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179 [Abstract] [Full Text] [Related]
15. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae. Shepard CC. Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):96-101. PubMed ID: 7042616 [No Abstract] [Full Text] [Related]
20. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae. Dhople AM. Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472 [Abstract] [Full Text] [Related] Page: [Next] [New Search]